These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2956875)

  • 21. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV; Meiler SE; Matthews S; Unverferth DV
    Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.
    Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H
    J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of enoximone in chronic heart failure.
    Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term therapy of chronic cardiac insufficiency using enoximone].
    Treese N; Erbel R; Rhein S; Diefenbach C; Alken RG; Mohr-Kahaly S; Meyer J
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1163-9. PubMed ID: 2956080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G; Butzer F; Dieterich HA; Heinrich F
    Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
    Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ
    Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic therapy of severe heart failure with enoximone.
    Gilfrich HJ; Witzke-Gross J; Römer A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S75-7. PubMed ID: 2480490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
    Treese N; Erbel R; Rhein S; Henrichs KJ; Meyer J
    Eur Heart J; 1989 Jun; 10(6):484-92. PubMed ID: 2527155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of dobutamine and enoximone for low output states following cardiac surgery.
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S13-9. PubMed ID: 2145233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
    Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
    J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.
    McDonald KM; O'Sullivan JJ; McWilliams EW; Conroy RC; Maurer BJ
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):913-8. PubMed ID: 2535057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
    Berti S; Palmieri C; Ravani M; Bonini R; Iascone MR; Clerico A; Manfredi C; Iervasi G; Ferrazzi P; Biagini A
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):81-7. PubMed ID: 8723174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.